About
Zymeworks Inc. Common Stock (NASDAQ:ZYME) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 16 2026
Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
Apr 9 2026
Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth
Apr 1 2026
Zymeworks Appoints Kristin Stafford as Chief Financial Officer
Mar 30 2026
Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate
Mar 18 2026
Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting
Financials
Revenue
$105.97 M
Market Cap
$1.92 B
EPS
-1.08
Google Übersetzer